Aggregator

Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity

2 weeks 6 days ago

MTI Viewpoints Insights shared by industry relative to healthcare and the advancement of medical technology. Peter Justen is Founder and CEO of AmeriTrust Solutions. He works at the intersection of technology, data, and human-centered design to improve access to government programs and streamline administrative processes. Hospitals and health systems make real-time decisions about patient care,…

Continue reading →

The post Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity appeared first on MedTech Intelligence.

Rich West

Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.

2 weeks 6 days ago

Market Access is now the central input into M&A and value-driven divestitures, enabling MedTech leaders to reshape portfolios for strategic advantage, long-term growth, and greater value to patients - unlocking their full potential.

The post Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook. appeared first on MedTech Intelligence.

Rich West

The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation

2 weeks 6 days ago

Boston Children’s Hospital physicians say one of the greatest risks in pediatric ICUs is delayed de-escalation of care, which can expose children to prolonged ventilation, sedation, and vasoactive medications. They argue that AI-driven clinical intelligence can help clinicians identify safer timing for weaning and extubation, supporting recovery and improving long-term outcomes.

The post The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation appeared first on MedTech Intelligence.

Rich West

Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System

2 weeks 6 days ago

Artivion has finalized its acquisition of Endospan Ltd., adding the FDA-approved NEXUS Aortic Arch System to its portfolio of aortic arch therapies. The deal strengthens the company’s position in the growing endovascular aortic repair market and adds a pipeline of next-generation arch technologies.

The post Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System appeared first on MedTech Intelligence.

Rich West